Cerebral aspergillosis in the era of new antifungals: the CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS).
Fiche publication
Date publication
novembre 2021
Journal
The Journal of infection
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HERBRECHT Raoul
Tous les auteurs :
Serris A, Benzakoun J, Danion F, Porcher R, Sonneville R, Wolff M, Kremer S, Letscher-Bru V, Fekkar A, Hekimian G, Pourcher V, Bougnoux ME, Poirée S, Ader F, Persat F, Cotton F, Tattevin P, Gangneux JP, Lelièvre L, Cassaing S, Bonneville F, Houze S, Bretagne S, Herbrecht R, Lortholary O, Naggara O, Lanternier F,
Lien Pubmed
Résumé
Cerebral aspergillosis (CA) is a life-threatening disease for which diagnosis and management remain challenging. Detailed analyses from large cohorts are lacking.
Mots clés
cerebral aspergillosis, galactomannan, invasive fungal disease
Référence
J Infect. 2021 Nov 24;: